393 related articles for article (PubMed ID: 31519178)
1. Long-term use of interferon-β in multiple sclerosis increases Vδ1
Maimaitijiang G; Watanabe M; Shinoda K; Isobe N; Nakamura Y; Masaki K; Matsushita T; Yoshikai Y; Kira JI
J Neuroinflammation; 2019 Sep; 16(1):179. PubMed ID: 31519178
[TBL] [Abstract][Full Text] [Related]
2. Association of Decreased Percentage of Vδ2
Maimaitijiang G; Shinoda K; Nakamura Y; Masaki K; Matsushita T; Isobe N; Yamasaki R; Yoshikai Y; Kira JI
Front Immunol; 2018; 9():748. PubMed ID: 29692781
[TBL] [Abstract][Full Text] [Related]
3. Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection.
Pihl RMF; Smith-Mahoney EL; Olson A; Yuen RR; Asundi A; Lin N; Belkina AC; Snyder-Cappione JE
J Infect Dis; 2024 May; 229(5):1317-1327. PubMed ID: 38390982
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen.
Wang C; Lai AY; Baiu DC; Smith KA; Odorico JS; Wilson K; Schreiber T; de Silva S; Gumperz JE
J Immunol; 2024 Jan; 212(2):284-294. PubMed ID: 37991420
[TBL] [Abstract][Full Text] [Related]
5. Aberrant phenotypes of circulating γδ-T cells may be involved in the onset of systemic lupus erythematosus.
Yuan S; Wang C; Zeng Y; Li J; Li W; He Z; Ye J; Li F; Chen Y; Lin X; Xu Y; Yu N; Cai X
Lupus; 2024 May; 33(6):587-597. PubMed ID: 38506324
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
Negash M; Tsegaye A; Wassie L; Howe R
BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
[TBL] [Abstract][Full Text] [Related]
9. Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets after Haploidentical Hematopoietic Stem Cell Transplantation.
Bian Z; Xu LP; Fu Q; Huo M; Liu L; Zhao X; Huang XJ; Liu J
Biol Blood Marrow Transplant; 2018 Feb; 24(2):252-259. PubMed ID: 29061533
[TBL] [Abstract][Full Text] [Related]
10. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.
Migalovich Sheikhet H; Villacorta Hidalgo J; Fisch P; Balbir-Gurman A; Braun-Moscovici Y; Bank I
Front Immunol; 2018; 9():753. PubMed ID: 29706966
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD161+ Vδ1+ γδ T cells in systemic sclerosis: association with interstitial pneumonia.
Segawa S; Goto D; Horikoshi M; Kondo Y; Umeda N; Hagiwara S; Yokosawa M; Hirota T; Miki H; Tsuboi H; Ogishima H; Suzuki T; Matsumoto I; Sumida T
Rheumatology (Oxford); 2014 Dec; 53(12):2259-69. PubMed ID: 24972843
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Vδ1(+) and Vδ2(+) γδ T cell subsets in acute liver allograft rejection.
Yu X; Liu Z; Wang Y; Wang H; Zhang M; Sun Y; Su H; Jin L; Wang F; Shi M
Transpl Immunol; 2013 Dec; 29(1-4):118-22. PubMed ID: 24029467
[TBL] [Abstract][Full Text] [Related]
14. Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection.
Oyoshi MK; Nagata H; Kimura N; Zhang Y; Demachi A; Hara T; Kanegane H; Matsuo Y; Yamaguchi T; Morio T; Hirano A; Shimizu N; Yamamoto K
Am J Pathol; 2003 May; 162(5):1629-38. PubMed ID: 12707047
[TBL] [Abstract][Full Text] [Related]
15. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.
Wistuba-Hamprecht K; Martens A; Haehnel K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Demuth I; Steinhagen-Thiessen E; Larbi A; Schilling B; Schadendorf D; Wolchok JD; Blank CU; Pawelec G; Garbe C; Weide B
Eur J Cancer; 2016 Sep; 64():116-26. PubMed ID: 27400322
[TBL] [Abstract][Full Text] [Related]
16. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity.
Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee HG; Boon T; Coulie P; van der Bruggen P
Eur J Immunol; 1997 Dec; 27(12):3368-79. PubMed ID: 9464825
[TBL] [Abstract][Full Text] [Related]
17. Increased Frequencies of Circulating IFN-γ-Producing Vδ1(+) and Vδ2(+) γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection.
Conroy MJ; Mac Nicholas R; Taylor M; O'Dea S; Mulcahy F; Norris S; Doherty DG
Viral Immunol; 2015 May; 28(4):201-8. PubMed ID: 25789722
[TBL] [Abstract][Full Text] [Related]
18. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
[TBL] [Abstract][Full Text] [Related]
19. Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer.
Kuroda H; Saito H; Ikeguchi M
Gastric Cancer; 2012 Oct; 15(4):433-9. PubMed ID: 22252158
[TBL] [Abstract][Full Text] [Related]
20. Long-term disability outcomes in relapsing-remitting multiple sclerosis: a 10-year follow-up study.
Drulovic J; Ivanovic J; Mesaros S; Martinovic V; Kisic-Tepavcevic D; Dujmovic I; Pekmezovic T
Neurol Sci; 2019 Aug; 40(8):1627-1636. PubMed ID: 31011930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
